CC BY-NC-ND 4.0 · Endosc Int Open 2023; 11(01): E107-E116
DOI: 10.1055/a-1990-0509
Original article

Sessile serrated lesion detection rates continue to increase: 2008–2020

Nicholas Edwardson
1   University of New Mexico, School of Public Administration, Albuquerque, New Mexico, United States
,
Prajakta Adsul
2   University of New Mexico, Department of Internal Medicine, Albuquerque, New Mexico, United States
3   University of New Mexico, Comprehensive Cancer Center, Cancer Control and Population Sciences, Albuquerque, New Mexico, United States
,
Zorisadday Gonzalez
2   University of New Mexico, Department of Internal Medicine, Albuquerque, New Mexico, United States
,
V. Shane Pankratz
2   University of New Mexico, Department of Internal Medicine, Albuquerque, New Mexico, United States
3   University of New Mexico, Comprehensive Cancer Center, Cancer Control and Population Sciences, Albuquerque, New Mexico, United States
,
Gulshan Parasher
2   University of New Mexico, Department of Internal Medicine, Albuquerque, New Mexico, United States
4   University of New Mexico, Department of Gastroenterology, Albuquerque, New Mexico, United States
,
Kevin English
5   Albuquerque Area Indian Health Board Inc., Albuquerque Area Southwest Tribal Epidemiology Center, Albuquerque, New Mexico, United States
,
Shiraz Mishra
3   University of New Mexico, Comprehensive Cancer Center, Cancer Control and Population Sciences, Albuquerque, New Mexico, United States
6   University of New Mexico, Department of Pediatrics, Albuquerque, New Mexico, United States
› Author Affiliations
This work was supported by the National Cancer Institute of the National Institutes of Health, grants R01CA192967 (Mishra, PI) and 3P30CA118100-16S4 (Tomkinson PI, Mishra, PD), and the Biostatistics Shared Resource of the University of New Mexico Comprehensive cancer Center, USA

Abstract

Background and study aims We assessed sessile serrated lesion detection rate (SSLDR) at a large academic medical center from 2008 to 2020 and modeled a local, aspirational target SSLDR. We also assessed SSLDRs among all gastroenterology fellows to better understand the relationship between SSLDRs and total colonoscopies performed.

Patients and methods SSL-positive pathology results were flagged from a dataset composed of all screening colonoscopies for average-risk patients from 2008 to 2020. Unadjusted SSLDRs were calculated for individual endoscopists by year. A mixed effects logistic regression was used to estimate the log odds of SSL detection, with one model estimating division-wide predictors of SSL detection and a second model focused exclusively on colonoscopies performed by fellows. Model-adjusted SSLDRs were estimated for all 13 years and across both categories of all endoscopists and fellows only.

Results Adjusted SSLDRs showed a consistent improvement in SSLDR from a low of 0.37 % (95 % confidence interval [CI]: 0.10–0.63) in 2008 to a high of 7.94 % (95 % CI: 6.34–9.54) in 2020. Among fellows only, the odds of SSL detection were significantly lower during their first year compared to their second year (OR: 0.80, 95 % CI: 0.66–0.98) but not significantly higher in their third year compared to their second year (OR: 1.09, 95 % CI: 0.85–1.4).

Conclusions SSLDR increased steadily and significantly throughout our study period but variance among endoscopists persists. The peak SSLDR from 2020 of 7.94 % should serve as the local aspirational target for this division’s attendings and fellows but should be continuously reevaluated.



Publication History

Received: 13 July 2022

Accepted after revision: 17 November 2022

Article published online:
26 January 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Siegel RL, Miller KD, Fuchs HE. et al. Cancer statistics, 2021. CA: Cancer J Clinicians 2021; 71: 7-33
  • 2 National Cancer Institute. Surveillance, Epidemiology, and End Results Program – Cancer Stat Facts: Colorectal Cancer. In: Surveillance E, and End Results Program ed. 2021
  • 3 Shaukat A, Kahi CJ, Burke CA. et al. ACG Clinical Guidelines: Colorectal Cancer Screening 2021. Am J Gastroenterol 2021; 116: 458-479
  • 4 Kahi CJ. Screening relevance of sessile serrated polyps. Clin Endosc 2019; 52: 235
  • 5 Kim SY, Kim TI. Serrated neoplasia pathway as an alternative route of colorectal cancer carcinogenesis. Intest Res 2018; 16: 358
  • 6 Karnes WE, Johnson DA, Berzin TM. et al. A polyp worth removing: a paradigm for measuring colonoscopy quality and performance of novel technologies for polyp detection. J Clin Gastroenterol 2021; 55: 733-739
  • 7 Shapiro JA, Bobo JK, Church TR. et al. A comparison of fecal immunochemical and high-sensitivity guaiac tests for colorectal cancer screening. Am J Gastroenterol 2017; 112: 1728
  • 8 Chang L-C, Shun C-T, Hsu W-F. et al. Fecal immunochemical test detects sessile serrated adenomas and polyps with a low level of sensitivity. Clin Gastroenterol Hepatol 2017; 15: 872-879.e871
  • 9 Anderson JC, Robertson DJ. Serrated polyp detection by the fecal immunochemical test: an imperfect FIT. Clin Gastroenterol Hepatol 2017; 15: 880-882
  • 10 Kim DH, Matkowskyj KA, Lubner MG. et al. Serrated polyps at CT colonography: prevalence and characteristics of the serrated polyp spectrum. Radiology 2016; 280: 455-463
  • 11 Desai M, Anderson JC, Kaminski M. et al. Sessile serrated lesion detection rates during average risk screening colonoscopy: A systematic review and meta-analysis of the published literature. Endosc Int Open 2021; 9: E610-E620
  • 12 Rameshshanker R, Purchiaroni F, Ana W. et al. PTH-039 Prevalence of sessile serrated adenomas/polyps in distal colon during screening colonoscopy/flexible sigmoidoscopy: a single bowel cancer screening experience from uk. Gut 2017; 66: A225
  • 13 Pohl H, Srivastava A, Bensen SP. et al. Incomplete polyp resection during colonoscopy – results of the complete adenoma resection (CARE) study. Gastroenterology 2013; 144: 74-80.e71
  • 14 Torlakovic E, Skovlund E, Snover DC. et al. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003; 27: 65-81
  • 15 Bettington M, Walker N, Clouston A. et al. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology 2013; 62: 367-386
  • 16 Abdeljawad K, Vemulapalli KC, Kahi CJ. et al. Sessile serrated polyp prevalence determined by a colonoscopist with a high lesion detection rate and an experienced pathologist. Gastrointest Endosc 2015; 81: 517-524
  • 17 Kanth P, Boylan KE, Bronner MP. et al. Molecular biomarkers of sessile serrated adenoma/polyps. Clin Translat Gastroenterol 2019; 10: e00104
  • 18 Hetzel JT, Huang CS, Coukos JA. et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol 2010; 105: 2656-2664
  • 19 Kahi CJ, Hewett DG, Norton DL. et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 2011; 9: 42-46
  • 20 Huang J, Chan PS, Pang TW. et al. Rate of detection of serrated lesions at colonoscopy in an average-risk population: a meta-analysis of 129,001 individuals. Endosc Int Open 2021; 9: E472-E481
  • 21 Kahi CJ, Rex DK. Sessile serrated lesions: Searching for the true prevalence. Endosc Int Open 2021; 9: E635-E636
  • 22 Ross WA, Thirumurthi S, Lynch PM. et al. Detection rates of premalignant polyps during screening colonoscopy: Time to revise quality standards?. Gastrointest Endosc 2015; 81: 567-574
  • 23 IJspeert J, Nolthenius CT, Kuipers E. et al. CT-colonography vs. colonoscopy for detection of high-risk sessile serrated polyps. Am J Gastroenterol 2016; 111: 516-522
  • 24 Shaukat A, Gravely AA, Kim AS. et al. Rates of detection of adenoma, sessile serrated adenoma, and advanced adenoma are stable over time and modifiable. Gastroenterol 2019; 156: 816-817
  • 25 Buda A, De Bona M, Dotti I. et al. Prevalence of different subtypes of serrated polyps and risk of synchronous advanced colorectal neoplasia in average-risk population undergoing first-time colonoscopy. Clin Translat Gastroenterol 2012; 3: e6
  • 26 Aziz M, Fatima R, Lee-Smith W. et al. Comparing endoscopic interventions to improve serrated adenoma detection rates during colonoscopy: a systematic review and network meta-analysis of randomized controlled trials. Eur J Gastroenterol Hepatol 2020; 32: 1284-1292
  • 27 Qayed E, Vora R, Levy S. et al. Colonoscopy procedural volume increases adenoma and polyp detection rates in gastroenterologytrainees. World J Gastrointest Endosc 2017; 9: 540-551
  • 28 Pace D, Borgaonkar M, Lougheed M. et al. Effect of colonoscopy volume on quality indicators. Can J Gastroenterol Hepatol; 2016 2580894.
  • 29 Zwink N, Stock C, Birkner B. et al. Screening colonoscopy volume and detection of colorectal neoplasms: a state-wide study from Bavaria, Germany. Europ J Cancer Prev 2017; 26: 181-188
  • 30 Peters SL, Hasan AG, Jacobson NB. et al. Level of fellowship training increases adenoma detection rates. Clin Gastroenterol Hepatol 2010; 8: 439-442
  • 31 Rogart JN, Siddiqui UD, Jamidar PA. et al. Fellow involvement may increase adenoma detection rates during colonoscopy. Am J Gastroenterol 2008; 103: 2841-2846
  • 32 Aziz M, Mehta TI, Weissman S. et al. Do water-aided techniques improve serrated polyp detection rate during colonoscopy? A systematic review with meta-analysis. J Clin Gastroenterol 2021; 55: 520-527